Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $106.75 Average Target Price from Brokerages
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned a consensus rating of “Buy” from the ...
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug
The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...